🇺🇸 FDA
Patent

US 8211428

Protease screening methods and proteases identified thereby

granted A61KA61K38/00A61P

Quick answer

US patent 8211428 (Protease screening methods and proteases identified thereby) held by Catalyst Biosciences, Inc. expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
59
CPC classes
A61K, A61K38/00, A61P, A61P1/00, A61P1/02